Could something as simple as a mineral or vitamin really shift the trajectory of type 2 diabetes? It’s a question both patients and clinicians increasingly ask as supplements gain popularity and more studies explore their potential benefits. While standard treatments remain foundational, micronutrients like magnesium and vitamin D have sparked …

When treating patients with diabetes, lifestyle advice such as “eat healthy” and “stay active” is often routine. But what if we took that a step further and issued a formal exercise prescription — in other words, ordering physical activity like we would a drug? Recent research suggests that a structured …

In diabetes care, “therapeutic inertia” refers to the failure to escalate or modify treatment when a patient’s glucose control is suboptimal. Even now — when newer, more effective treatments and monitoring tools are widely available — therapeutic inertia in diabetes remains a stubborn barrier. Providers often wait too long before …

Starting insulin early in the course of type 2 diabetes may seem counter‑intuitive. After all, many patients and clinicians treat insulin as a “last resort.” Yet what if early insulin initiation could actually change the trajectory of the disease — preserving pancreatic function, improving long‑term control, and reducing complications? In …

The class of medications known as GLP-1 receptor agonists — commonly prescribed for type 2 diabetes and increasingly used for weight loss — may offer more than just metabolic benefits. Growing evidence indicates that GLP-1 drugs could play a role in protecting the brain. Could this mean a dual benefit …

Imagine a virtual version of yourself, a “mirror you” inside a computer, where doctors and you can test different treatments, diets, or lifestyle changes — without any risk. This is not science fiction anymore. In recent years, researchers have begun applying the concept of “digital twins diabetes” — virtual patient …